Quay Pharma is now part of sgs logoopens in a new window


Company Overview


Quay Pharma is fully licensed for the clinical manufacture of live biotherapeutics products.

Read MoreWatch Now

Quay Pharma is experienced in formulation development and is one of the few companies licensed for the clinical manufacture of live biotherapeutics targeted for digestive, urogenital, otorhinologic, and pulmonary delivery.

Live Biotherapeutics projects demand bespoke solutions. Quay Pharma are recognised as a world-leader in live-biotherapeutics drug formulation development and clinical manufacture. Our vast experience and scientific know-how means every project is approached in a way that no other CDMO can match.

By understanding the client dosing requirements for the live biotherapeutic, Quay can prepare a formulation development strategy to bring it rapidly and effectively to First in Human (FIH) studies and further clinical use to provide a formulation with the best chance of clinical outcome. Without the correct delivery and release strategy for your drug product formulation, your LBP project will likely fail. Talk to us first.

Our formulation development and clinical services include:

  • Immediate release and controlled release tablets.
  • Multilayer tablets.
  • Immediate-release capsules.
  • Oral multiparticulates such as beads, pellets and mini-tablets.
  • Liquid and semi-solid filled capsules.
  • Fast dispersible tablets.
  • Coating of tablets, capsules and pellets.
  • Micro-encapsulation using spray drying.
  • Oral liquids and suspensions.

Dosage forms include:

  • Capsules.
  • Liquids and semi-solids for topical delivery, such as creams, ointments, lotions and gels.
  • Buccal delivery.
  • Nasal sprays.
  • Dental products.
  • Pessaries.
  • Suppositories.

Talk to Quay Pharma and maximise your chances of project success.

The Benefits of Enteric Coating: Case Study

One of the questions we are asked most by our clients is which capsule technology we would recommend they use. The two main capsule technologies available, which offer enteric protection, are enteric capsule shells and enteric-coated capsules. We have ran an disintegration test comparing the two types, please follow the link below to view the results:

View Results

Let's Talk Project Success

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us  
Your Dedicated Contacts
Michael Kruidenier
Head of Business Development

Michael joined Quay Pharma in Sept 2013 and he is responsible for all global Live Biotherapeutic business and for all other business outside Europe. Most of Michael’s career has been spent in commercial roles. He has over 30 years of Sales and Marketing experience, including 20 years in the pharmaceutical industry with Proctor & Gamble and SCA followed by working for leading contract service organisations PERA and Penn Pharma.

Ryan Wilson
Head of Live-Biotherapeutics Programme

Ryan, with 30 years knowledge of drug development and manufacturing for small molecules and biologicals, Ryan brings a wealth of knowledge to Quay.  Overseeing strategic new development projects at Quay, Ryan has been instrumental in Quays leading position in the formulation development and clinical manufacture of live biotherapeutics.

Our Pharmaceutical Services

Drug Development Services

SGS PACE (Product Accelerated Clinically Enabled) helps you bring the vision of your new drug to life - Faster.

Find Out More

Preclinical Formulation

Robust formulation development strategies tailored to the characteristics of each individual API.

Find Out More


Analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges.

Find Out More

Pharmaceutical Formulation Development

Dosage form optimisation for a wide range of product types including those that have poor solubility or bioavailability.

Find Out More

Analytical Services

Analytical specialists working alongside our formulation and manufacturing teams which provide expert advice.

Find Out More

Phase I Clinical Manufacturing

Early clinical formulations and clinical manufacturing of First in Human trials and clinical evaluations of your API.

Find Out More

Phase II & III Clinical Manufacturing

Fully equipped and accredited to manufacture a wide range of products for Phase II and small-scale Phase III trials.

Find Out More

Commercial Manufacturing

MHRA licensed to include commercial manufacture. Services include contract packaging and assembly...

Find Out More

Controlled Substances

Over ten years of extensive development and manufacture experience converting controlled substances into a variety of different dosage forms.

Find Out More

Clinical Trial Supply

Complete range of clinical trial supply packaging for solid and liquid dosages. Despatched with full QP release certification.

Find Out More

Live Biotherapeutics Drug Delivery

One of the few companies licensed for the clinical manufacture of live biotherapeutics products.

Find Out More

Orphan Drugs

Perfectly equipped to deliver an Orphan Drug molecule from preclinical and formulation development to small scale commercialisation.

Find Out More

Specials Manufacturing

One of the limited number of contract manufacturers who hold an MRHA license for the manufacture and supply of ‘specials’.

Find Out More

Let's Talk Project Success

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us